帕金森病与脑脊液中的胺类代谢产物：对左旋多巴治疗的启示 - Suppr | 超能文献

Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.

作者信息

Korf J, van Praag H M, Schut D, Nienhuis R J, Lakke J P

出版信息

Eur Neurol. 1974;12(5-6):340-50. doi: 10.1159/000114631.

DOI:10.1159/000114631

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.帕金森病与脑脊液中的胺类代谢产物：对左旋多巴治疗的启示

Eur Neurol. 1974;12(5-6):340-50. doi: 10.1159/000114631.

2

Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluid.静脉注射丙磺舒负荷剂量。对血浆和脑脊液中丙磺舒水平以及脑脊液中单胺代谢产物的影响。

Neurology. 1976 Oct;26(10):992-6. doi: 10.1212/wnl.26.10.992.

3

Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.帕金森病脑脊液中的胺类代谢产物及其对左旋多巴的反应。

J Neurol Sci. 1973 May;19(1):1-12. doi: 10.1016/0022-510x(73)90050-6.

4

Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.单独使用左旋多巴或与脱羧酶抑制剂联合治疗的帕金森病患者脑脊液中的酸性单胺代谢产物。

Eur Neurol. 1973;9(6):349-62. doi: 10.1159/000114243.

5

Dopaminergic nervous transmission in Parkinson's disease.帕金森病中的多巴胺能神经传递

Med Biol. 1974 Jun;52(3):208-17.

6

Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.左旋多巴及左旋多巴+RO 4-4602治疗的帕金森病患者临床症状、脑脊液中高香草酸（HVA）和5-羟吲哚乙酸（5-HIAA）与血浆左旋多巴的相关性

Eur J Clin Pharmacol. 1977 Apr 20;11(4):255-61. doi: 10.1007/BF00607673.

7

[Cerebrospinal fluid amine metabolites and L-dopa in vegetative state patients (author's transl)].植物状态患者的脑脊液胺类代谢产物与左旋多巴（作者译）

No Shinkei Geka. 1978 Mar;6(3):235-43.

8

Homovanillic acid in the cerebrospinal fluid of Parkinsonian patients.帕金森病患者脑脊液中的高香草酸

Can J Neurol Sci. 1983 Feb;10(1):43-6. doi: 10.1017/s0317167100044553.

9

Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.锥体外系运动障碍患者脑脊液中神经递质代谢产物及3',5'-环磷酸腺苷的分析

Adv Neurol. 1984;40:431-5.

10

Unresponsiveness to L-DOPA in parkinsonian patients: a study of homovanillic acid concentration in the cerebrospinal fluid.帕金森病患者对左旋多巴无反应：脑脊液中高香草酸浓度的研究

J Neurol Sci. 1989 Aug;92(1):65-70. doi: 10.1016/0022-510x(89)90175-5.

引用本文的文献

1

Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.多部位脑内微透析研究帕金森病脑中 L-DOPA 诱导的多巴胺和 5-羟色胺释放的机制。

ACS Chem Neurosci. 2013 May 15;4(5):680-92. doi: 10.1021/cn400046e. Epub 2013 Apr 15.

2

Clinical pharmacokinetics of levodopa in parkinson's disease.帕金森病中左旋多巴的临床药代动力学

Clin Pharmacokinet. 1976;1(5):313-38. doi: 10.2165/00003088-197601050-00001.